文献速递造血干细胞移植与细胞治疗

近10年来单中心供者特征对T细胞充足单倍体造血干细胞移植的影响

Effect of donor characteristics on T cell-replete haploidentical stem cell transplantation over the last 10 years at a single institution.
PubMed 文献 · Br J Haematol · 2021-12-03

该前瞻性队列研究纳入512例接受基于抗胸腺细胞球蛋白的单倍体造血干细胞移植(haplo-SCT)的血液恶性肿瘤患者,旨在确定影响移植结局的最重要供者因素。供者年龄增加与较差的总生存(OS)相关(HR 1.08,P=0.044),女性供者至男性受者与更高的非复发死亡(NRM;HR 2.05,P=0.006)显著相关。在有多名单倍体供者可选时, preferred 选择较年轻供者,年轻受者(<35岁)优先年轻同胞,年长受者(≥35岁)优先年轻子女,并避免女性供者至男性受者。

要点

  • 供者年龄增加与较差OS相关(HR 1.08,P=0.044)。
  • 女性供者至男性受者与更高NRM(HR 2.05,P=0.006)和2-4级aGVHD(HR 1.50,P=0.022)相关。
  • <35岁患者中同胞供者OS、DFS和NRM优于父母供者;≥35岁患者中同胞供者NRM高于子女供者。

核心结论

  • 在有多名单倍体供者可选时, preferred 选择较年轻供者,年轻受者(<35岁)优先年轻同胞,年长受者(≥35岁)优先年轻子女,并避免女性供者至男性受者。

研究设计与样本

  • 前瞻性队列研究,纳入512例接受基于抗胸腺细胞球蛋白的单倍体造血干细胞移植(haplo-SCT)的血液恶性肿瘤患者。

主要发现

  • 供者年龄增加与较差的总生存(OS)相关(HR 1.08,P=0.044)。
  • 女性供者至男性受者与更高的非复发死亡(NRM)显著相关(HR 2.05,P=0.006)。
  • 供者年龄增加与3-4级急性移植物抗宿主病(aGVHD)风险升高相关(HR 1.17,P=0.005)。
  • 女性供者至男性受者与2-4级aGVHD风险升高相关(HR 1.50,P=0.022)。
  • 在<35岁患者中,同胞供者的OS、无病生存(DFS)和NRM优于父母供者;在≥35岁患者中,同胞供者的NRM高于子女供者。

临床怎么用

  • 作者建议,在有多名单倍体供者可选时, preferred 选择较年轻供者,年轻受者(<35岁)优先年轻同胞,年长受者(≥35岁)优先年轻子女,并避免女性供者至男性受者。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

One of the most complex issues with haploidentical stem cell transplantation (haplo-SCT) is donor selection, given that multiple haploidentical donors are often available for a given recipient. To develop evidence-based guidance for donor selection in the setting of anti-thymocyte globulin-based haplo-SCT, we performed a prospective cohort study of 512 patients with haematological malignancies who had haplo-SCT to determine which donor variables were most important in favouring transplant outcomes. Increasing donor age was associated with poorer overall survival (OS) [hazard ratio (HR) 1·08, P = 0·044]. Female donors to male recipients was significantly associated with higher non-relapse mortality (NRM; HR 2·05, P = 0·006). Furthermore, increasing donor age had a higher risk of Grades 3-4 acute graft-versus-host disease (aGVHD; HR 1·17, P = 0·005), female donors to male recipients was associated with a higher risk of Grades 2-4 aGVHD (HR 1·50, P = 0·022). Sibling donors had superior OS, disease-free survival, and NRM than parental donors in patients aged <35 years. However, sibling donors had higher NRM than offspring donors in patients aged ≥35 years. A younger donor, usually a young sibling in younger recipients (aged <35 years) or a young offspring in older patients (aged ≥35 years) and avoiding female donors to male recipients should be preferred when multiple haploidentical donors are available.

来源:Br J Haematol,查看原文。版权归原作者所有。

引用

  1. Wu Y, Lai X, Shi J, et al. Effect of donor characteristics on T cell-replete haploidentical stem cell transplantation over the last 10 years at a single institution. Br J Haematol. 2021. PMID: 34859418. doi:10.1111/bjh.17978

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。